Showing results (241-250 of 412) with videos related to

Sort By:
Pageof 42
Gastroenterology|March 24, 2009
Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosisFiona Oakley, Victoria Teoh, Gemma Ching-A-Sue, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 3, 2025
Heart Transplantation and Donation After Circulatory Death in Children. A Review of the Technological, Logistical and Ethical FrameworkLouise Amelia Kenny, Liz Armstrong, Marius Berman, et al.
The European Journal of General Practice|May 17, 2022
Chronic hepatitis C: Diagnosis and treatment made easyNaim Abu-Freha, Binil Mathew Jacob, Ali Elhoashla, et al.
Epilepsy Research|September 26, 2006
Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamideEyal Sobol, Boris Yagen, John G Lamb, et al.
Archives of Disease in Childhood|February 14, 2012
Continuous EEG monitoring in Kenyan children with non-traumatic comaSamson Gwer, Richard Idro, Gregory Fegan, et al.
Epilepsy Research|January 24, 2017
Seizure detection and neuromodulation: A summary of data presented at the XIII conference on new antiepileptic drug and devices (EILAT XIII)Meir Bialer, Svein I Johannessen, René H Levy, et al.
Epilepsia|October 29, 2018
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). I. Drugs in preclinical and early clinical developmentMeir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia|October 29, 2018
Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical developmentMeir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Epilepsia|January 19, 2017
Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokineticsCameron S Metcalf, Brian D Klein, Daniel R McDougle, et al.
Epilepsy Research|March 27, 2019
A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV)Meir Bialer, Svein I Johannessen, Matthias J Koepp, et al.
Pageof 42